60 Degrees Pharmaceuticals (SXTP) Equity Ratio (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Equity Ratio for 4 consecutive years, with 0.65 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio fell 19.13% to 0.65 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.65, a 19.13% decrease, with the full-year FY2024 number at 0.7, up 13.67% from a year prior.
- Equity Ratio was 0.65 for Q3 2025 at 60 Degrees Pharmaceuticals, up from 0.56 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.85 in Q1 2024 to a low of 18.62 in Q4 2022.
- A 4-year average of 1.43 and a median of 0.67 in 2025 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: soared 120.36% in 2024, then dropped 20.75% in 2025.
- 60 Degrees Pharmaceuticals' Equity Ratio stood at 18.62 in 2022, then skyrocketed by 103.31% to 0.62 in 2023, then increased by 13.67% to 0.7 in 2024, then fell by 7.26% to 0.65 in 2025.
- Per Business Quant, the three most recent readings for SXTP's Equity Ratio are 0.65 (Q3 2025), 0.56 (Q2 2025), and 0.67 (Q1 2025).